These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18584574)

  • 21. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia.
    Löscher W; Richter A
    Eur J Pharmacol; 2000 Mar; 391(3):251-4. PubMed ID: 10729365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of levetiracetam on spike and wave discharges in WAG/Rij rats.
    Bouwman BM; van Rijn CM
    Seizure; 2004 Dec; 13(8):591-4. PubMed ID: 15519920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
    Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
    J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levetiracetam].
    Salas-Puig J; Calleja S
    Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review.
    Watkins AK; Gee ME; Brown JN
    J Clin Pharm Ther; 2018 Aug; 43(4):467-475. PubMed ID: 29781197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam safety profiles and tolerability in epilepsy patients.
    Briggs DE; French JA
    Expert Opin Drug Saf; 2004 Sep; 3(5):415-24. PubMed ID: 15335297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.
    Palma E; Ragozzino D; Di Angelantonio S; Mascia A; Maiolino F; Manfredi M; Cantore G; Esposito V; Di Gennaro G; Quarato P; Miledi R; Eusebi F
    Epilepsia; 2007 Oct; 48(10):1842-9. PubMed ID: 17521347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of efficacy of levetiracetam in oromandibular and cranial dystonia.
    Park JE; Srivanitchapoom P; Maurer CW; Mathew P; Sackett J; Paine R; Ramos VL; Hallett M
    Acta Neurol Scand; 2017 Aug; 136(2):103-108. PubMed ID: 27808417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label study of levetiracetam for the treatment of social anxiety disorder.
    Simon NM; Worthington JJ; Doyle AC; Hoge EA; Kinrys G; Fischmann D; Link N; Pollack MH
    J Clin Psychiatry; 2004 Sep; 65(9):1219-22. PubMed ID: 15367048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.
    Gower AJ; Hirsch E; Boehrer A; Noyer M; Marescaux C
    Epilepsy Res; 1995 Nov; 22(3):207-13. PubMed ID: 8991787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam.
    Pietrzak B; Czarnecka E
    Alcohol; 2008 Mar; 42(2):115-22. PubMed ID: 18358990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
    Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
    Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
    Sisodiya SM; Sander JW; Patsalos PN
    Epilepsy Res; 2002 Feb; 48(3):217-9. PubMed ID: 11904240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.